Literature DB >> 17300929

Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.

David Robinson1, Risto Sankila, Timo Hakulinen, Henrik Møller.   

Abstract

We have assessed the impact on survival estimates based on cancer registry data of incomplete ascertainment of cancer cases and the presence of cases registered purely from death certificate information (DCO cases). Using data from the Thames and Finnish Cancer Registries we obtained five-year relative survival estimates for 12 cancer sites, excluding DCOs as usual. We then made adjustments to allow for the effects of both the known proportion of DCOs and the estimated proportion of missing cases for each site. In general, adjusting for DCOs led to lower survival estimates, whilst adjusting for incompleteness had the opposite effect. The Finnish data were largely complete and had small proportions of DCOs, and hence the adjustments had little effect on estimated survival. The changes in the Thames estimates were more marked. When performing cohort survival analysis (based on diagnoses between 1990 and 1994), the increases in the survival estimates gained from adjusting for incompleteness were for the most part offset by the decrease produced when adjusting for DCOs. However, when performing period survival analysis based on the period 1997-2001 (when the DCO rate at Thames had fallen by around a half relative to the earlier period), the final estimates (adjusted for both effects) were generally higher than the unadjusted values--thus reducing the apparent difference between the two countries. It is important to take variations in DCO proportion and/or completeness into consideration when comparing survival estimates between different populations.

Entities:  

Mesh:

Year:  2007        PMID: 17300929     DOI: 10.1016/j.ejca.2007.01.007

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  18 in total

1.  Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study.

Authors:  Peter Vedsted; Frede Olesen
Journal:  Br J Gen Pract       Date:  2011-08       Impact factor: 5.386

Review 2.  Explanations for worsening cancer survival.

Authors:  Esther de Vries; Henrike E Karim-Kos; Maryska L G Janssen-Heijnen; Isabelle Soerjomataram; Lambertus A Kiemeney; Jan Willem W Coebergh
Journal:  Nat Rev Clin Oncol       Date:  2010-01       Impact factor: 66.675

3.  Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5.

Authors:  L A Anderson; A Tavilla; H Brenner; S Luttmann; C Navarro; A T Gavin; B Holleczek; B T Johnston; M B Cook; F Bannon; M Sant
Journal:  Eur J Cancer       Date:  2015-09-26       Impact factor: 9.162

4.  Baseline mortality-adjusted survival in resected rectal cancer patients.

Authors:  Ignazio Tarantino; Sascha A Müller; Rene Warschkow; Yakup Kulu; Bruno M Schmied; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

5.  The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004.

Authors:  Yien Ning S Wong; Ruth H Jack; Vivian Mak; Møller Henrik; Elizabeth A Davies
Journal:  BMC Cancer       Date:  2009-06-29       Impact factor: 4.430

6.  Long-Term Survival is not Impaired After the Complete Resection of Neuroendocrine Tumors of the Appendix.

Authors:  Thomas Steffen; Sabrina M Ebinger; René Warschkow; Cornelia Lüthi; Bruno M Schmied; Thomas Clerici
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

7.  Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates.

Authors:  H Møller; S Richards; N Hanchett; S P Riaz; M Lüchtenborg; L Holmberg; D Robinson
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

8.  Predictors of early death in female patients with breast cancer in the UK: a cohort study.

Authors:  Ceilidh Stapelkamp; Lars Holmberg; Daniela Tataru; Henrik Møller; David Robinson
Journal:  BMJ Open       Date:  2011-11-28       Impact factor: 2.692

9.  A visual summary of the EUROCARE-4 results: a UK perspective.

Authors:  H Møller; K M Linklater; D Robinson
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

10.  A comprehensive assessment of the impact of errors in the cancer registration process on 1- and 5-year relative survival estimates.

Authors:  M J Rutherford; H Møller; P C Lambert
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.